Management of Persistent Dizziness

Introduction to Vestibular Rehabilitation

• The American Academy of Otolaryngology-Head and Neck Surgery recommends vestibular rehabilitation therapy as the primary intervention for persistent dizziness that has failed multiple medication trials, promoting central compensation and long-term recovery 1, 2
• Vestibular rehabilitation therapy has been shown to significantly improve measures of overall gait stability compared to medication alone, particularly in patients with residual dizziness after treatment for BPPV 1
• The American Academy of Otolaryngology-Head and Neck Surgery suggests that vestibular rehabilitation therapy is especially indicated when balance and motion tolerance do not improve in a timely manner despite medication trials 1

Pharmacological Interventions

• Betahistine (typically 16-48 mg three times daily) may be effective in reducing symptoms in specific patient subgroups, particularly those over 50 years old with hypertension and symptom onset less than 1 month, according to the American Academy of Otolaryngology-Head and Neck Surgery 2, 3
• The American Academy of Otolaryngology-Head and Neck Surgery advises that vestibular suppressant medications should only be used for short-term management of severe symptoms rather than as definitive treatment 4, 1, 2

Diagnostic Considerations

• The American Academy of Otolaryngology-Head and Neck Surgery recommends confirming the diagnosis and ruling out central causes of vertigo, ensuring proper diagnosis of vertigo type, as different types require different treatments 5, 6
• Neuroimaging should be considered if central vertigo is suspected, according to the American Academy of Otolaryngology-Head and Neck Surgery 7

Lifestyle Modifications

• Limiting salt/sodium intake, avoiding excessive caffeine, alcohol, and nicotine, maintaining adequate hydration, regular exercise, and sufficient sleep, and implementing appropriate stress management techniques are recommended by the American Academy of Otolaryngology-Head and Neck Surgery 5, 8
• The American Academy of Otolaryngology-Head and Neck Surgery suggests that these lifestyle modifications can help manage persistent dizziness 5, 8

Important Cautions

• Long-term use of vestibular suppressants can interfere with central compensation in peripheral vestibular conditions, potentially prolonging symptoms, according to the American Academy of Otolaryngology-Head and Neck Surgery 6, 8
• All vestibular suppressants may cause drowsiness, cognitive deficits, and interference with driving or operating machinery, and significantly increase fall risk, especially in elderly patients, as warned by the American Academy of Otolaryngology-Head and Neck Surgery 2, 3
• Reassessing patients within 1 month after initiating treatment to document resolution or persistence of symptoms is recommended by the American Academy of Otolaryngology-Head and Neck Surgery 2, 9

Management of Persistent Dizziness

Diagnostic Reassessment

• Reassess patients within 1 month after initial treatment to document resolution or persistence of symptoms, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 10

First-Line Treatment Approach

• For BPPV, canalith repositioning procedures are significantly more effective (78.6%-93.3% improvement) than medication alone (30.8% improvement), according to the American Academy of Otolaryngology-Head and Neck Surgery 10
• All vestibular suppressants may cause drowsiness, cognitive deficits, and significantly increase fall risk, especially in elderly patients, as noted by the American Academy of Otolaryngology-Head and Neck Surgery 10

Medication Considerations

• Benzodiazepines are a significant independent risk factor for falls and should be discontinued, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 10
• Betahistine has shown mixed evidence for efficacy, with recent high-quality trials showing no significant difference between betahistine and placebo for vertigo control, according to the American Academy of Otolaryngology-Head and Neck Surgery 11, 12

Alternative Therapeutic Options

• For Ménière's disease with persistent symptoms, consider intratympanic steroid therapy, as suggested by the American Academy of Otolaryngology-Head and Neck Surgery 11, 12

Important Cautions

• Avoid polypharmacy, as the risk of falls increases in patients taking multiple medications, as warned by the American Academy of Otolaryngology-Head and Neck Surgery 10
• Be particularly cautious with vestibular suppressants in elderly patients due to increased risk of cognitive dysfunction, falls, and drug interactions, as advised by the American Academy of Otolaryngology-Head and Neck Surgery 10

Follow-Up Recommendations

• Reassess patients within 1 month after initiating treatment to document resolution or persistence of symptoms, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 10

Treatment of Chronic Dizziness

Vestibular Rehabilitation and Medication Management

• The American Academy of Otolaryngology-Head and Neck Surgery emphasizes that increased balance performance is achieved only when movement/habituation-based vestibular rehabilitation is administered, not with repositioning procedures alone 13
• Vestibular suppressant medications should NOT be used routinely for chronic dizziness and should only be reserved for short-term management of severe acute symptoms 13
• No evidence suggests vestibular suppressants are effective as definitive primary treatment for chronic vestibular disorders 13
• Canalith repositioning maneuvers demonstrate 78.6%-93.3% improvement versus only 30.8% with medication alone 13
• Patients who underwent repositioning maneuvers alone recovered faster than those who received concurrent vestibular suppressants 13

Treatment of Specific Underlying Conditions

• The Epley maneuver shows 80% vertigo resolution at 24 hours versus 13% with sham treatment 14
• The Semont maneuver demonstrates 94.2% symptom resolution at 6 months versus 57.7% with flunarizine and 34.6% with no treatment 14
• Recurrence rates are 10-18% at 1 year and may reach 36% over time, requiring patient counseling 15

Fall Prevention Counseling

• Patients with chronic dizziness are at significantly increased risk for falls 15
• 36.7% of elderly patients with chronic vestibular disorders carry a diagnosis of BPPV 15
• 53% of elderly patients with chronic vestibular disorders had fallen at least once in the past year 15
• 29.2% of elderly patients with chronic vestibular disorders had recurrent falls 15
• Provide fall prevention counseling including home safety assessment, activity restrictions, and need for supervision, particularly in elderly and frail patients 15

Follow-Up Protocol

• Detection of atypical symptoms (hearing loss, gait disturbance, non-positional vertigo) that warrant further evaluation for underlying vestibular or CNS disorders 15

Common Pitfalls to Avoid

• Do not prescribe vestibular suppressants as long-term therapy 13

Meclizine Use in Elderly Patients with Vertigo

Critical Safety Concerns and Alternative Approaches

• In frail elderly or those with limited life expectancy, meclizine is considered eligible for deprescribing and may be inappropriate, according to the British Journal of Pharmacology 16
• Elderly patients with long-standing Ménière's disease may present with "vague dizziness" rather than frank vertigo, making accurate diagnosis and appropriate treatment selection more challenging, as noted by the American Academy of Otolaryngology-Head and Neck Surgery 17, 18

Clinical Decision Algorithm

• When evaluating elderly patients with vertigo, it is essential to confirm true vertigo, identify the specific cause, and rule out dangerous causes, such as stroke, cardiovascular disease, or neurologic conditions that may present as vertigo, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 17, 18